• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Beverly Moy, MD, MPH


  • Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM, .Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial.Lancet Oncol. 2013 Jan;14(1):88-96.
  • Boutrus RR, Abi Raad RF, Kuter I, Ancukiewicz M, Roberts L, Solomon N, Ngo T, Borick H, Ryan P, Moy B, Gadd M, Chien J, Younger J, Smith B, Taghian AG, Harris L.Circulating tumor cells as predictors of response and failure in breast cancer patients treated with preoperative chemotherapy.Int J Biol Markers. 2012 Sep 17:0.
  • Vaz-Luis I, Ottesen RA, Hughes ME, Marcom PK, Moy B, Rugo HS, Theriault RL, Wilson J, Niland JC, Weeks JC, Lin NU.Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.Breast Cancer Res. 2012 Oct 1;14(5):R129.
  • Raj A, Ko N, Battaglia TA, Chabner BA, Moy B.Patient navigation for underserved patients diagnosed with breast cancer.Oncologist. 2012;17(8):1027-31.
  • Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN.Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery.BMC Med Inform Decis Mak. 2012;12:51.
  • Morris PG, Chen C, Steingart RM, Fleisher M, Lin NU, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler MN, McArthur HL, Winer EP, Norton L, Hudis C, Dang CT.Troponin I and C-Reactive Protein are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib.Clin Cancer Res. 2011 Mar 3.
  • Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K.Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].Plast Reconstr Surg. 2011 Jan;127(1):18-26.
  • Dang C, Lin N, Moy B, Come S, Sugarman S, Morris P, Abbruzzi A, Chen C, Steingart R, Patil S, Norton L, Winer E, Hudis C.Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrhea.J Clin Oncol. 2010 Jun 20;28(18):2982-8.
  • Swan JS, Ying J, Stahl J, Kong CY, Moy B, Roy J, Halpern E.Initial development of the Temporary Utilities Index: a multiattribute system for classifying the functional health impact of diagnostic testing.Qual Life Res. 2010 Apr;19(3):401-12.
  • Morris PG, Dickler M, McArthur HL, Traina T, Sugarman S, Lin N, Moy B, Come S, Godfrey L, Nulsen B, Chen C, Steingart R, Rugo H, Norton L, Winer E, Hudis CA, Dang CT.Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.J Clin Oncol. 2009 Dec 20;27(36):6117-23.
  • Sepucha KR,Ozanne EM,Partridge AH,Moy B.Is There a Role for Decision Aids in Advanced Breast Cancer?.Med Decis Making.;29(4):475-82.
  • Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR.Doctor-patient communication about advance directives in metastatic breast cancer.J Palliat Med. 2009 Jun;12(6):547-53.
  • Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD.Institutional academic industry relationships.JAMA. 2007 Oct 17;298(15):1779-86.
  • Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 May 24;16(10).
  • Moy B, Goss PE.Lapatinib-associated toxicity and practical management recommendations.Oncologist. 2007 Jul;12(7):756-65. Review.
  • Moy B, Goss PE.TEACH: Tykerb evaluation after chemotherapy.Clin Breast Cancer. 2007 Feb;7(6):489-92.
  • del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS.Mammographic breast density and race.AJR Am J Roentgenol. 2007 Apr;188(4):1147-50.
  • Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 Oct;16(10):895-903.
  • Moy B, Goss PE.Lapatinib: current status and future directions in breast cancer.Oncologist. 2006 Nov-Dec;11(10):1047-57. Review.
  • Moy B, Tu D, Pater JL, Ingle JN, Shepherd LE, Whelan TJ, Goss PE.Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.Ann Oncol. 2006 Nov;17(11):1637-43.
  • Moy B, Goss PE.Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches.Clin Cancer Res. 2006 Aug 15;12(16):4790-3. Review.
  • Moy B, Park ER, Feibelmann S, Chiang S, Weissman JS.Barriers to repeat mammography: cultural perspectives of African-American, Asian, and Hispanic women.Psychooncology. 2006 Jul;15(7):623-34.
  • Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.J Clin Oncol. 2005 Nov 20;23(33):8340-7.
  • Campbell EG, Moy B, Feibelmann S, Weissman JS, Blumenthal D.Institutional academic industry relationship: results of interviews with university leaders.Account Res. 2004 Apr-Jun;11(2):103-18.
  • Blanchard K, Colbert JA, Puri D, Weissman J, Moy B, Kopans DB, Kaine EM, Moore RH, Halpern EF, Hughes KS, Tanabe KK, Smith BL, Michaelson JS.Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.Cancer. 2004 Aug 1;101(3):495-507.
  • Moy B, Wang JC, Raffel GD, Marcoux JP.Hemolytic uremic syndrome associated with clopidogrel: a case report.Arch Intern Med. 2000 May 8;160(9):1370-2.